Discover the latest research, insights, and breakthroughs in precision health, artificial intelligence, and human optimization from our team of experts.
Testosterone gets all the hype in muscle-building circles—but for natural athletes, it’s the least controllable anabolic hormone. This post explores the real hormonal drivers of hypertrophy—testosterone, GH/IGF-1, and insulin—and reveals why insulin, not testosterone, is the most powerful and practical lever for maximizing muscle growth.
Menopause is not the end—it’s a biological transition that reshapes a woman’s hormonal, skeletal, and metabolic landscape. This post breaks down the science behind the hormonal shifts, the misunderstood role of estrogen therapy, the urgent need to preserve bone density, and why resistance training is non-negotiable for long-term strength and vitality.
While Rybelsus® is currently the only semaglutide-based option available in India, many mistakenly believe Ozempic® is on the market. This post clears the confusion, comparing Rybelsus®, Ozempic®, and Mounjaro®—from their pharmacology and effectiveness to their availability and future in India’s healthcare system.
Weight loss advice is often written for men—but women face a completely different metabolic reality. From lower caloric needs and hormonal barriers to misleading fitness advice, this post breaks down why fat loss is so much harder for women, and why the key is rapid, biology-aligned intervention—not slow, male-centric plans.
Testosterone is more than a number—it’s a genomic hormone that shapes how your body functions over time. Learn why standard test results often mislead, why SHBG and FAI matter more than you think, and when low T is actually a sign of cellular maturity—not dysfunction.
India’s healthcare future won’t be defined by more hospitals—it will be shaped by prevention, technology, and accessibility. This post explores how India can reimagine healthcare through primary care reform, digital health infrastructure, affordable innovation, and population-scale personalization—building a system that’s proactive, inclusive, and built for 1.4 billion lives.
While Mounjaro® may be the gold standard in obesity pharmacology, it’s semaglutide (Ozempic®)—soon to be available as a low-cost generic in India—that could truly reshape the nation’s healthcare landscape. With multiple Indian pharma companies filing for approval and prices set to drop by over 80%, semaglutide offers a scalable, population-level solution to India’s growing metabolic crisis.
Testosterone is more than a number—it’s a genomic hormone that shapes how your body functions over time. Learn why standard test results often mislead, why SHBG and FAI matter more than you think, and when low T is actually a sign of cellular maturity—not dysfunction.
Get the latest research and insights delivered directly to your inbox